Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia - Implications for diabetes therapy

被引：13

作者：

Carroll, MF ^{[1
]}

Izard, A ^{[1
]}

Riboni, K ^{[1
]}

Burge, MR ^{[1
]}

Schade, DS ^{[1
]}

机构：

[1] Univ New Mexico, Ctr Hlth Sci, Dept Internal Med, Albuquerque, NM 87131 USA

来源：

DIABETES CARE | 2002年 / 25卷 / 07期

关键词：

D O I：

10.2337/diacare.25.7.1247

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1247 / 1248

页数：2

共 7 条

[1] Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes [J].

Avignon, A ;

Radauceanu, A ;

Monnier, L .

DIABETES CARE, 1997, 20 (12) :1822-1826

[2] Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes -: Implications for treatment and monitoring of metabolic control [J].

Bonora, E ;

Calcaterra, F ;

Lombardi, S ;

Bonfante, N ;

Formentini, G ;

Bonadonna, RC ;

Muggeo, M .

DIABETES CARE, 2001, 24 (12) :2023-2029

[3]

Borch-Johnsen K, 1999, LANCET, V354, P617

[4]

Gerstein HC, 2001, DIABETES, V50, pA114

[5] Risk factors for myocardial infarction and death in newly detected NIDDM: The diabetes intervention study, 11-year follow-up [J].

Hanefeld, M ;

Fischer, S ;

Julius, U ;

Schulze, J ;

Schwanebeck, U ;

Schmechel, H ;

Ziegelasch, HJ ;

Lindner, J .

DIABETOLOGIA, 1996, 39 (12) :1577-1583

[6] A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas [J].

Landgraf, R ;

Bilo, HJG ;

Müller, PG .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (03) :165-171

[7] Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study [J].

Willms, B ;

Ruge, D .

DIABETIC MEDICINE, 1999, 16 (09) :755-761

← 1 →